| 0 (0%) | 11-11 15:53 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 48.21 | 1-year : | 56.31 |
| Resists | First : | 41.27 | Second : | 48.21 |
| Pivot price | 38.71 |
|||
| Supports | First : | 37.72 | Second : | 35.52 |
| MAs | MA(5) : | 39.27 |
MA(20) : | 38.74 |
| MA(100) : | 34.04 |
MA(250) : | 27.05 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 69.6 |
D(3) : | 60.8 |
| RSI | RSI(14): 63.7 |
|||
| 52-week | High : | 41.27 | Low : | 17.81 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ KNSA ] has closed below upper band by 3.2%. Bollinger Bands are 10.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 39.84 - 40.04 | 40.04 - 40.24 |
| Low: | 38.11 - 38.31 | 38.31 - 38.52 |
| Close: | 39.17 - 39.5 | 39.5 - 39.82 |
Tue, 11 Nov 2025
Connor Clark & Lunn Investment Management Ltd. Has $17.26 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Mon, 10 Nov 2025
Heatmap analysis for KNSA and competitors - Trade Exit Report & Safe Capital Growth Plans - newser.com
Mon, 10 Nov 2025
Is KNSA stock attractive for passive investors - IPO Watch & Entry Point Strategy Guides - newser.com
Sun, 09 Nov 2025
Fox Run Management L.L.C. Buys 24,391 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Sun, 09 Nov 2025
Heatmap analysis for KNSA and competitors - July 2025 Decliners & Weekly Top Gainers Alerts - newser.com
Sat, 08 Nov 2025
Is Kiniksa’s Upbeat 2025 Sales Outlook Reshaping the Investment Case for KNSA? - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 43 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 3.7 (%) |
| Held by Institutions | 92.5 (%) |
| Shares Short | 2,560 (K) |
| Shares Short P.Month | 2,430 (K) |
| EPS | 0.05 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.69 |
| Profit Margin | 0.8 % |
| Operating Margin | 12.8 % |
| Return on Assets (ttm) | 0.4 % |
| Return on Equity (ttm) | 1 % |
| Qtrly Rev. Growth | 44.2 % |
| Gross Profit (p.s.) | 6.46 |
| Sales Per Share | 12.17 |
| EBITDA (p.s.) | 0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 67 (M) |
| Levered Free Cash Flow | 39 (M) |
| PE Ratio | 814.59 |
| PEG Ratio | 0 |
| Price to Book value | 6.08 |
| Price to Sales | 3.34 |
| Price to Cash Flow | 26.44 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|